MAM
RGNX icon

Meeder Asset Management’s Regenxbio RGNX Stock Holding History

Meeder Asset Management’s Portfolio RGNX Stock Details RGNX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-51
Closed -$1K – 1731
2022
Q3 		$1K Sell
51
-86
-63% -$2.55K ﹤0.01% 2006
2022
Q2 		$3K Buy
137
+29
+27% +$725 ﹤0.01% 1823
2022
Q1 		$4K Buy
+108
New +$3K ﹤0.01% 1875
2021
Q4 		– Sell
-1,443
Closed -$60K – 2079
2021
Q3 		$60K Buy
1,443
+1,356
+1,559% +$48.8K ﹤0.01% 1046
2021
Q2 		$3K Buy
87
+66
+314% +$2.36K ﹤0.01% 2129
2021
Q1 		$1K Hold
21
– – ﹤0.01% 2253
2020
Q4 		$1K Sell
21
-8
-28% -$280 ﹤0.01% 1721
2020
Q3 		$1K Sell
29
-64
-69% -$2.09K ﹤0.01% 2036
2020
Q2 		$3K Sell
93
-399
-81% -$14.9K ﹤0.01% 1688
2020
Q1 		$16K Buy
492
+137
+39% +$5.71K ﹤0.01% 1335
2019
Q4 		$15K Hold
355
– – ﹤0.01% 1440
2019
Q3 		$13K Buy
355
+262
+282% +$10.6K ﹤0.01% 1448
2019
Q2 		$5K Sell
93
-2,129
-96% -$106K ﹤0.01% 1676
2019
Q1 		$128K Sell
2,222
-356
-14% -$17.6K 0.01% 639
2018
Q4 		$109K Buy
2,578
+621
+32% +$36.4K 0.01% 622
2018
Q3 		$148K Sell
1,957
-221
-10% -$15.9K 0.01% 552
2018
Q2 		$156K Buy
2,178
+2,012
+1,212% +$96.1K 0.01% 542
2018
Q1 		$5K Sell
166
-190
-53% -$5.53K ﹤0.01% 1232
2017
Q4 		$12K Buy
356
+331
+1,324% +$9.97K ﹤0.01% 1079
2017
Q3 		$1K Buy
+25
New +$563 ﹤0.01% 1560
2017
Q2 		– Sell
-93
Closed -$2K – 1827
2017
Q1 		$2K Buy
+93
New +$1.79K ﹤0.01% 1395

Other funds holding RGNX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.49B AUM 208.7% 1-Year Est. Return
RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
ACM
Aquilo Capital Management San Francisco, California $55.8M AUM 41.76% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
MB
MPM BioImpact Boston, Massachusetts $1.64B AUM 245.64% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Meeder Asset Management's RGNX Position: Q4 2022 in Review

Meeder Asset Management sold out of Regenxbio (RGNX) in Q4 2022, closing a stake of 51 shares — an estimated $1K sold.

Meeder Asset Management first reported a position in RGNX in Q1 2017 and held it in 21 quarters. The position peaked at $156K in Q2 2018. 180 funds tracked by Wall St. Rank hold RGNX as of Q4 2022.

  • Meeder Asset Management reported no remaining Regenxbio position as of Q4 2022 after selling out during the quarter.
  • Meeder Asset Management sold 51 Regenxbio shares in Q4 2022, an estimated $1K.
  • Meeder Asset Management first reported a position in Regenxbio in Q1 2017 and held it in 21 quarters.
  • Meeder Asset Management's Regenxbio position peaked at $156K in Q2 2018.
  • 180 funds tracked by Wall St. Rank held Regenxbio as of Q4 2022.

Based on Meeder Asset Management's 13F filing for Q4 2022, filed 14 Feb 2023.